An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
about
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude micePrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaHistotripsy methods in mechanical disintegration of tissue: towards clinical applicationsResection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?Image-guided non-invasive ultrasound liver ablation using histotripsy: feasibility study in an in vivo porcine model.A multidisciplinary approach to the management of hepatocellular carcinoma.Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list.An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithmPredicting recurrence patterns after resection of hepatocellular cancer.Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort studyRacial, social, and clinical determinants of hepatocellular carcinoma surveillanceFrom minimal to maximal surgery in the treatment of hepatocarcinoma: A reviewTransplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection.Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.Hepatocellular carcinoma: From diagnosis to treatment.Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implicationsLoco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysisCurrent status of multimodal & combination therapy for hepatocellular carcinoma.Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.Outcomes Between Elderly and Young Hepatocellular Carcinoma Living Donor Liver Transplantation Recipients: A Single-Center Experience.COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL.National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapyLiver transplantation for hepatocellular carcinoma: an appraisal of current controversies.Which matters most: number of tumors, size of the largest tumor, or total tumor volume?Is the treatment of hepatocellular carcinoma on the waiting list necessary?Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma.Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.Targeted therapies in the treatment of advanced hepatocellular carcinoma90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.What's New in Transarterial Therapies for Hepatocellular Carcinoma?IS RESECTION OF HEPATOCELLULAR CARCINOMA IN THE ERA OF LIVER TRANSPLANTATION WORTHWILE? A single center experience.CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
P2860
Q21245479-F2140EEC-95ED-45C4-B06C-1C42193BF964Q26772329-F2B9F939-0517-4D88-98BC-F508679782CCQ28392783-4853FAE5-F856-446C-9886-9E1FED4F01CAQ28394414-48E3992A-553F-4B45-8127-FC98F75C5B5CQ30389693-A9BDA9A8-0222-4976-813C-8C0356E7CA38Q30410247-CEA7E98D-17B2-4DDF-93FA-6EF3E40288A0Q30433998-1781C8DB-3F9A-4657-8CB4-B15388711DC2Q33916361-45AFEB82-187D-4DA9-8D18-44FC488C1834Q34065055-1FA5DA1A-A5BB-4789-83BB-CEDF955B8104Q34417009-88062A25-0381-4642-B0A0-6CD044231B39Q34548943-E2E7BEB0-71DC-48CC-9A4A-6C606C81CEA7Q34600274-DDAD7E8F-E606-460A-9F9B-CE395FE356D7Q34808945-4EDF83D2-3239-4572-A55F-F930F96525E0Q34966860-8B7056D1-AE1C-404E-B65C-5BDD73EC38A8Q35064605-F4A71344-4EC3-4DC0-9EE8-F72CE970A442Q35081063-9EAFE264-E9C9-4F87-B60F-D0C0AB1588E5Q35207490-C1ECBBE5-7EB7-4741-8390-735AF9B32C36Q35207762-69F85B7B-8566-4568-97D3-74B3BD897489Q35668716-844BB77F-E9E9-4A35-8F60-1D9D71370627Q35759606-61435548-0EC9-46C9-B9D5-9074E0E356CBQ36063276-CD96CBFD-E00E-40B9-9F9C-14D55D45E667Q36436294-D284DCEA-AB41-4CC2-A5B0-836D5062A0FDQ36456976-AF3018A2-D47B-45BD-B788-14B840EC4DD2Q36566774-5AE86866-475C-43A9-BD60-EF2BEE15DC0AQ36852128-B37ABA7B-D8D8-49BF-9083-6F7715EF6636Q37000692-882AC970-582D-4465-964C-D987A47D10D5Q37034067-EEC7F12E-7F44-4F31-8F9F-EFDADE553BF6Q37140667-D274D713-B219-49E3-A008-FCF75748EBC9Q37876384-DB7686F9-69A8-49B1-9C44-755FC906BEE5Q37939790-4323E3B1-7A06-4BDE-8505-0D7ECBC3FA29Q37995306-8FCCF110-C1ED-4115-A2D1-06A2EEDD33EBQ38048224-9133B73F-36A9-4F18-85DB-AE87442A0313Q38114062-C061985D-42CD-4C72-BB31-445FB59D94C4Q38162894-267306AA-5CEE-4903-9A65-F64E956D8A77Q39179820-1EC6C6F2-3E62-45ED-AB71-646CA812AF97Q39572206-25CB076B-984C-421E-B77E-BAF1B2D90D43Q39580588-75D307A6-5EA1-4162-B756-5CFA7D354E10Q41308909-9C541DA4-C36E-489E-9EE5-E0E0DDDB188BQ42228465-61F8C030-5C00-4BF3-949B-84FF53FD7694Q42279683-DD62A851-5650-4BE2-B2A6-9411C8024AC4
P2860
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An intention-to-treat analysis ...... ement transplant network data.
@ast
An intention-to-treat analysis ...... ement transplant network data.
@en
type
label
An intention-to-treat analysis ...... ement transplant network data.
@ast
An intention-to-treat analysis ...... ement transplant network data.
@en
prefLabel
An intention-to-treat analysis ...... ement transplant network data.
@ast
An intention-to-treat analysis ...... ement transplant network data.
@en
P2093
P356
P1476
An intention-to-treat analysis ...... ement transplant network data.
@en
P2093
Anna S Lok
Carlos Romero-Marrero
Jeffrey D Punch
John C Magee
Jorge A Marrero
Mashal J Batheja
Robert J Fontana
Shawn J Pelletier
Veena Thyagarajan
P304
P356
10.1002/LT.21778
P577
2009-08-01T00:00:00Z